Sidi M. Niambele

Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial

Mehreen S. Datoo, Alassane Dicko, Halidou Tinto et al. · The Lancet · 2024 · 351 citations · Full text

Veterinary Medicine, Child Health, Pediatrics +17

Pyronaridine–artesunate or dihydroartemisinin–piperaquine combined with single low-dose primaquine to prevent Plasmodium falciparum malaria transmission in Ouélessébougou, Mali: a four-arm, single-blind, phase 2/3, randomised trial

William J. Stone, Almahamoudou Mahamar, Koualy Sanogo et al. · The Lancet Microbe · 2021 · 38 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Single low-dose tafenoquine combined with dihydroartemisinin–piperaquine to reduce Plasmodium falciparum transmission in Ouelessebougou, Mali: a phase 2, single-blind, randomised clinical trial

William J. Stone, Almahamoudou Mahamar, Merel Smit et al. · The Lancet Microbe · 2022 · 26 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacology +17

Artemether–lumefantrine with or without single-dose primaquine and sulfadoxine–pyrimethamine plus amodiaquine with or without single-dose tafenoquine to reduce Plasmodium falciparum transmission: a phase 2, single-blind, randomised clinical trial in Ouelessebougou, Mali

Almahamoudou Mahamar, Merel Smit, Koualy Sanogo et al. · The Lancet Microbe · 2024 · 20 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Artemether–lumefantrine–amodiaquine or artesunate–amodiaquine combined with single low-dose primaquine to reduce Plasmodium falciparum malaria transmission in Ouélessébougou, Mali: a five-arm, phase 2, single-blind, randomised controlled trial

Almahamoudou Mahamar, Leen N. Vanheer, Merel Smit et al. · The Lancet Microbe · 2024 · 17 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +17